<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>Novo Nordisk Pharmatech A/S</itunes:name>
            <itunes:email>mwvm@novonordisk.com</itunes:email>
        </itunes:owner>
        <title>Novo Nordisk Pharmatech A/S</title>
        <link>https://novonordiskpharmatechas.twentythree.com</link>
        <description></description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>Novo Nordisk Pharmatech A/S</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://novonordiskpharmatechas.twentythree.com/files/rv1.4/sitelogo.gif"/>
        <image>
            <url>https://novonordiskpharmatechas.twentythree.com/files/rv1.4/sitelogo.gif</url>
            <title>Novo Nordisk Pharmatech A/S</title>
            <link>https://novonordiskpharmatechas.twentythree.com</link>
        </image>
        <atom:link rel="self" href="https://novonordiskpharmatechas.twentythree.com/podcast/tag/DoE"/>
        <atom:link rel="next" href="https://novonordiskpharmatechas.twentythree.com/podcast/tag/DoE?tag=DoE&amp;p=2&amp;podcast%5fp=t&amp;https="/>
        <item>
            <enclosure url="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/video_medium/why-use-recombinant-insulin-in-doe-video.mp4?source=podcast" type="video/mp4" length="51800911"/>
            <title>Why Use Recombinant Insulin in DoE For Your Media Development?</title>
            <link>http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe</link>
            <description>&lt;p&gt;The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://novonordiskpharmatechas.twentythree.com/photo/85911454</guid>
            <pubDate>Thu, 11 Mar 2021 00:00:00 GMT</pubDate>
            <media:title>Why Use Recombinant Insulin in DoE For Your Media Development?</media:title>
            <itunes:summary>The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.</itunes:summary>
            <itunes:subtitle>The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association...</itunes:subtitle>
            <itunes:author>Novo Nordisk Pharmatech A/S</itunes:author>
            <itunes:duration>18:09</itunes:duration>
            <media:description type="html">&lt;p&gt;The presentation features a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells, as well as examining the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.&lt;/p&gt;&lt;p&gt;&lt;a href="http://novonordiskpharmatechas.twentythree.com/why-use-recombinant-insulin-in-doe"&gt;&lt;img src="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://novonordiskpharmatechas.twentythree.com/v.ihtml/player.html?token=55196b7b52f6282acee5dd7de97c9bdf&amp;source=podcast&amp;photo%5fid=85911454" width="625" height="352" type="text/html" medium="video" duration="1089" isDefault="true" expression="full"/>
            <media:thumbnail url="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://novonordiskpharmatechas.twentythree.com/64968575/85911454/55196b7b52f6282acee5dd7de97c9bdf/standard/download-10-thumbnail.jpg/thumbnail.jpg"/>
            <category>DoE</category>
            <category>growth factor</category>
            <category>media development</category>
            <category>Recombinant Insulin</category>
        </item>
    </channel>
</rss>
